OWP Pharmaceuticals is a commercial-stage neuroscience specialty pharmaceutical company dedicated to developing and commercializing novel oral liquid formulations, particularly for neurological disorders. The company supports providers and patients in the U. S. with beneficial medications while also donating profits to support educational and medical initiatives for those with neurological disorders in under-resourced areas globally, reflecting their commitment to social impact in healthcare.
November 13
Drive sales strategy for Meitheal Pharmaceuticals' generics and biosimilars.
November 13
Account Representative driving sales for Meitheal Pharmaceuticals' injectable and biologics products.